Comment from Arnold Ventures

Summary: Arnold Ventures, a philanthropy focused on evidence-based policy, supports the development of master protocols for clinical trials but recommends specific enhancements to the draft guidance. They argue for stronger requirements for randomization to internal control groups, more emphasis on double-blinded trials over partially blinded ones, and clearer expectations for statistical analysis plans regarding interim results and concurrent enrollment.